Short answer
Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on June 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Mario Schlosser transitions from President of Technology and CTO to Co-Founder & Advisor to the CEO effective June 1, 2026.
Oscar Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Mario Schlosser transitions from President of Technology and CTO to Co-Founder & Advisor to the CEO effective June 1, 2026
- Continued Board service and AI, digital-health responsibilities preserve strategic technology involvement
- Base salary resets to $370,000, with no annual bonus eligibility beginning in 2026
- No new long-term incentive awards; previously granted equity continues vesting under existing terms
- No cash severance or company-subsidized healthcare upon termination, reducing future compensation obligations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oscar Health, Inc. 8-K filings
Get the next OSCR 8-K as it lands
Follow OSCR for push alerts, or ask the research agent what this filing means.